Omega Diagnostics Group Plc (ODX)

London
3.40
-0.05(-1.45%)
  • Volume:
    507,957
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    3.40 - 3.40

ODX Overview

Prev. Close
3.45
Day's Range
3.4-3.4
Revenue
11.3M
Open
3.45
52 wk Range
3.01-73.6
EPS
-0.02
Volume
507,957
Market Cap
7.91M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
4,035,000
P/E Ratio
-
Beta
4.41
1-Year Change
-94.85%
Shares Outstanding
232,682,404
Next Earnings Date
Jul 11, 2022
What is your sentiment on Omega?
or
Market is currently closed. Voting is open during market hours.

Omega Diagnostics Group Plc Analysis

Omega Diagnostics Group Plc Company Profile

Omega Diagnostics Group Plc Company Profile

Omega Diagnostics Group PLC is a medical diagnostics company. The Company's segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers. For allergy, it offers Allergodip, which is an enzyme immunoassay for the semi-quantitative determination of Specific immunoglobulin E (IgE) in serum or plasma. For anemia, it offers ATHOZYME Ferritin, which is an enzyme-immunoassay (ELISA) test for the detection and quantification of Ferritin in human serum. It offers a range of products for Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Antiphospholipid Syndrome (APS), Connective Tissue Disease, Gastrointestinal, and Vasculitis and Renal Disease. Its Fertility Hormones products include PATHOZYME-LH (Luteinizing Hormone), PATHOZYME-Prolactin and PATHOZYME-Oestradiol.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellSellStrong BuyStrong SellStrong Sell
SummaryStrong SellSellStrong SellStrong SellStrong Sell
  • I think that tweet over the weekend was purposely tweeted to drop the SP so the directors could buy more prior to the big announcement.
    0
    • Do you have any news on omega?
      0
  • Omega Diagnostics confirms deal with UK to manufacture Covid lateral flow tests.Everything falling into place here.
    0
    • Getting really exciting now, endorsement as a key UK government manufacturer in the FT. Government orders in the pipeline. Huge upside.
      0
      • This SP will easily reach £2 this year. Strong fundamentals, orders are around the corner. MHRA Approval imminent. US, India and China orders coming soon.
        1
        • In four months, this company will be manufacturing 2m+ C-19 tests / week with an avg profit of £1 / test. It will generate more profit more than its current mcap. It has a huge diversification of high quality tests in partnership with Mologic and a part of the UK-RTC set up by the uk gov. The company also has food intolerance and CD4 divisions as well as developing LFT for Cryptococcus and TB -LAM, underpinning the company's value post covid. Price target of 250p (£475m mcap)
          1
          • Or in four months this company could still be sat waiting for orders, capacity is one thing... but IP and orders is what counts. On the covid front they have neither.
            3
        • Biolidics Enters Distribution Agreement With Mediproud Co for COVID19 test Kits
          0